Related Experiment Video
Updated: Mar 24, 2026
06:49
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
Published on: October 6, 2015
21.1K
Predicting Disease Progression and Survival in Amyotrophic Lateral Sclerosis
Muhannad Seyam1,2,3, Kathryn H Morelli1, Waqar Waheed1
1Department of Neurological Sciences and Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.
Muscle & Nerve
|March 23, 2026
Summary
Early respiratory phenotyping in amyotrophic lateral sclerosis (ALS) can improve patient stratification and disease progression assessment. This approach aids in predicting survival and optimizing therapeutic interventions for ALS patients.
Area of Science:
- Neurology
- Respiratory Medicine
- Clinical Trials
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with variable progression and survival rates.
- Current challenges in ALS management include determining optimal intervention timing and effective patient stratification for clinical trials.
- Disease progression in ALS is difficult to accurately capture, hindering research and treatment efficacy assessment.
Purpose of the Study:
- To investigate early respiratory phenotyping as a method for improving ALS patient stratification.
- To assess the utility of respiratory phenotyping in enhancing disease progression assessments.
- To determine if early respiratory phenotyping can predict survival in ALS patients.
Main Methods:
- The study proposes utilizing early respiratory assessments to phenotype patients with ALS.
- Methods focus on analyzing respiratory function markers at early stages of the disease.
- Statistical models are employed to correlate respiratory phenotypes with disease progression and survival outcomes.
Main Results:
- Early respiratory phenotyping demonstrates potential for stratifying ALS patients based on disease trajectory.
- Respiratory markers show promise in providing more accurate assessments of longitudinal disease progression.
- Preliminary findings suggest a correlation between specific respiratory phenotypes and patient survival.
Conclusions:
- Early respiratory phenotyping is a valuable tool for enhancing ALS patient stratification.
- This approach can improve the reliability of disease progression assessments in ALS clinical trials.
- Respiratory phenotyping offers a promising strategy for predicting survival and guiding therapeutic interventions in amyotrophic lateral sclerosis.
Related Concept Videos
01:21Cancer Survival Analysis
820
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
820
01:15Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K